LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 16

Search options

  1. Article ; Online: Persistent post-COVID-19 neuromuscular symptoms.

    Abrams, Rory M C / Zhou, Lan / Shin, Susan C

    Muscle & nerve

    2023  Volume 68, Issue 4, Page(s) 350–355

    Abstract: Neuromuscular symptoms may develop or persist after resolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Besides residual sensorimotor symptoms associated with acute neuromuscular complications of coronavirus disease-2019 ...

    Abstract Neuromuscular symptoms may develop or persist after resolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Besides residual sensorimotor symptoms associated with acute neuromuscular complications of coronavirus disease-2019 (COVID-19), such as Guillain-Barré syndrome, critical illness neuromyopathy, and rhabdomyolysis, patients may report persistent autonomic symptoms, sensory symptoms, and muscle symptoms in the absence of these acute complications, including palpitations, orthostatic dizziness and intolerance, paresthesia, myalgia, and fatigue. These symptoms may be associated with long COVID, also known as post-COVID-19 conditions or postacute sequelae of SARS-CoV-2 infection, which may significantly impact quality of life. Managing these symptoms represents a challenge for health-care providers. Recent advances have identified small-fiber neuropathy as a potential etiology that may underlie autonomic dysfunction and paresthesia in some long COVID patients. The pathogenic mechanisms underlying myalgia and fatigue remain elusive and need to be investigated. Herein we review the current state of knowledge regarding the evaluation and management of patients with persistent post-COVID-19 neuromuscular symptoms.
    MeSH term(s) Humans ; COVID-19/complications ; SARS-CoV-2 ; Post-Acute COVID-19 Syndrome ; Myalgia/etiology ; Paresthesia/etiology ; Quality of Life ; Fatigue/etiology ; Primary Dysautonomias
    Language English
    Publishing date 2023-07-19
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 438353-9
    ISSN 1097-4598 ; 0148-639X
    ISSN (online) 1097-4598
    ISSN 0148-639X
    DOI 10.1002/mus.27940
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Management of Neuropathic Pain in the Geriatric Population.

    Pedowitz, Elizabeth J / Abrams, Rory M C / Simpson, David M

    Clinics in geriatric medicine

    2021  Volume 37, Issue 2, Page(s) 361–376

    Abstract: Neuropathic pain is common in the geriatric population. Diagnosis requires a thorough history and physical examination to differentiate it from other types of pain. Once diagnosed, further workup is required to elucidate the cause, including potential ... ...

    Abstract Neuropathic pain is common in the geriatric population. Diagnosis requires a thorough history and physical examination to differentiate it from other types of pain. Once diagnosed, further workup is required to elucidate the cause, including potential reversible causes of neuropathy. When treating neuropathic pain in the elderly, it is important to consider patients' comorbidities and other medications to avoid drug-drug interactions and iatrogenic effects given the physiologic changes of drug metabolism in the elderly. Nonsystemic therapies and topical medications should be considered. Systemic medications should be started at low dose and titrated up slowly with frequent monitoring for adverse effects.
    MeSH term(s) Aged ; Analgesics/therapeutic use ; Analgesics, Opioid/therapeutic use ; Complementary Therapies/methods ; Disease Management ; Geriatric Assessment ; Geriatrics ; Humans ; Neuralgia/diagnosis ; Neuralgia/etiology ; Neuralgia/therapy ; Patient-Centered Care
    Chemical Substances Analgesics ; Analgesics, Opioid
    Language English
    Publishing date 2021-03-23
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1064151-8
    ISSN 1879-8853 ; 0749-0690
    ISSN (online) 1879-8853
    ISSN 0749-0690
    DOI 10.1016/j.cger.2021.01.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Comment on small fiber neuropathy associated with SARS-CoV-2 infection: Author response.

    Abrams, Rory M C / Simpson, David M / Navis, Allison / Jette, Nathalie / Zhou, Lan / Shin, Susan C

    Muscle & nerve

    2022  Volume 65, Issue 6, Page(s) E32–E33

    MeSH term(s) COVID-19/complications ; Humans ; SARS-CoV-2 ; Small Fiber Neuropathy/complications ; Small Fiber Neuropathy/diagnosis
    Language English
    Publishing date 2022-04-19
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 438353-9
    ISSN 1097-4598 ; 0148-639X
    ISSN (online) 1097-4598
    ISSN 0148-639X
    DOI 10.1002/mus.27555
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults.

    Abrams, Rory M C / Pedowitz, Elizabeth J / Simpson, David M

    Expert review of neurotherapeutics

    2021  Volume 21, Issue 3, Page(s) 259–266

    Abstract: Introduction: Diabetes is an increasingly prevalent disorder affecting nearly 1-in-5 adults, of which half will experience diabetic peripheral neuropathy (DPN) and a quarter will suffer from diabetic peripheral nerve pain (DPNP), severely impacting ... ...

    Abstract Introduction: Diabetes is an increasingly prevalent disorder affecting nearly 1-in-5 adults, of which half will experience diabetic peripheral neuropathy (DPN) and a quarter will suffer from diabetic peripheral nerve pain (DPNP), severely impacting quality of life. The currently approved treatment options are typically centrally acting agents whose use is limited by systemic effects and drug interactions. The capsaicin 8% dermal patch was recently approved by the U.S. FDA for the treatment of DPNP.
    Areas covered: The authors review the available literature regarding the use of high-concentration capsaicin 8% patch for the treatment of diabetic peripheral neuropathy and neuropathic pain and discuss implementing its use in clinical practice.
    Expert opinion: The high-concentration capsaicin 8% patch is an effective and well-tolerated treatment option for treating DPNP. Capsaicin 8% patch may be used alone or in combination with other oral therapies and can provide rapid and sustained neuropathic pain relief following a single application and is safe and effective when used long term.
    MeSH term(s) Adult ; Capsaicin/therapeutic use ; Diabetes Mellitus ; Diabetic Neuropathies/complications ; Diabetic Neuropathies/drug therapy ; Humans ; Neuralgia/drug therapy ; Pain Management ; Quality of Life
    Chemical Substances Capsaicin (S07O44R1ZM)
    Language English
    Publishing date 2021-02-04
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2112534-X
    ISSN 1744-8360 ; 1473-7175
    ISSN (online) 1744-8360
    ISSN 1473-7175
    DOI 10.1080/14737175.2021.1874920
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?

    Abrams, Rory M C / Safavi, Farinaz / Tuhrim, Stanley / Navis, Allison / Steinberger, Jeremy / Shin, Susan C

    Journal of neurovirology

    2021  Volume 27, Issue 4, Page(s) 650–655

    Abstract: Since the onset of the COVID-19 pandemic, there have been rare reports of spinal cord pathology diagnosed as inflammatory myelopathy and suspected spinal cord ischemia after SARS-CoV-2 infection. Herein, we report five cases of clinical myelopathy and ... ...

    Abstract Since the onset of the COVID-19 pandemic, there have been rare reports of spinal cord pathology diagnosed as inflammatory myelopathy and suspected spinal cord ischemia after SARS-CoV-2 infection. Herein, we report five cases of clinical myelopathy and myeloradiculopathy in the setting of post-COVID-19 disease, which were all radiographically negative. Unlike prior reports which typically characterized hospitalized patients with severe COVID-19 disease and critical illness, these patients typically had asymptomatic or mild-moderate COVID-19 disease and lacked radiologic evidence of structural spinal cord abnormality. This case series highlights that COVID-19 associated myelopathy is not rare, requires a high degree of clinical suspicion as imaging markers may be negative, and raises several possible pathophysiologic mechanisms.
    MeSH term(s) Aged ; COVID-19/complications ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; SARS-CoV-2 ; Spinal Cord Diseases/etiology ; Spinal Cord Diseases/pathology
    Language English
    Publishing date 2021-06-08
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 1283265-0
    ISSN 1538-2443 ; 1355-0284
    ISSN (online) 1538-2443
    ISSN 1355-0284
    DOI 10.1007/s13365-021-00986-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Variant Median Nerve Anatomy: Ultrasound Evidence of a Pseudoconduction Block.

    Abrams, Rory M C / Pedowitz, Elizabeth J / Simpson, David M / Shin, Susan C

    Journal of clinical neuromuscular disease

    2021  Volume 22, Issue 4, Page(s) 209–213

    Abstract: Introduction: A conduction block at a noncompressible site warrants further investigation.: Methods and materials: A 36-year-old woman with a history of Hodgkin lymphoma and chemotherapy-induced polyneuropathy developed bilateral hand numbness and ... ...

    Abstract Introduction: A conduction block at a noncompressible site warrants further investigation.
    Methods and materials: A 36-year-old woman with a history of Hodgkin lymphoma and chemotherapy-induced polyneuropathy developed bilateral hand numbness and paresthesias. Workup revealed bilateral carpal tunnel syndrome and an apparent superimposed conduction block of the median nerve in the forearm. Given the history of cancer, there was concern for an infiltrative or an immune-mediated process.
    Results: Neuromuscular ultrasound demonstrated that the median nerve descended the upper extremity along an atypical path, deep along the posteromedial aspect of the upper arm, and relatively medially in the forearm. Ultrasound-directed nerve stimulation revealed there was no conduction block. This anatomical variant has been rarely described and has not been reported previously to mimic conduction block or been documented via ultrasound.
    Conclusions: This case demonstrates that neuromuscular ultrasound may supplement the electrodiagnostic study and limit confounding technical factors because of rare anatomic variation.
    MeSH term(s) Adult ; Carpal Tunnel Syndrome/diagnostic imaging ; Electromyography ; Female ; Humans ; Median Nerve/diagnostic imaging ; Neural Conduction ; Paresthesia/diagnostic imaging ; Ultrasonography
    Language English
    Publishing date 2021-05-21
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1454947-5
    ISSN 1537-1611 ; 1522-0443
    ISSN (online) 1537-1611
    ISSN 1522-0443
    DOI 10.1097/CND.0000000000000325
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Small fiber neuropathy associated with SARS-CoV-2 infection.

    Abrams, Rory M C / Simpson, David M / Navis, Allison / Jette, Nathalie / Zhou, Lan / Shin, Susan C

    Muscle & nerve

    2021  Volume 65, Issue 4, Page(s) 440–443

    Abstract: Introduction/aims: The development and persistence of neurological symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is referred to as "long-haul" syndrome. We aimed to determine whether small fiber neuropathy ( ... ...

    Abstract Introduction/aims: The development and persistence of neurological symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is referred to as "long-haul" syndrome. We aimed to determine whether small fiber neuropathy (SFN) was associated with SARS-CoV-2 infection.
    Methods: We retrospectively studied the clinical features and outcomes of patients who were referred to us between May 2020 and May 2021 for painful paresthesia and numbness that developed during or after SARS-CoV-2 infection and who had nerve conduction studies showing no evidence of a large fiber polyneuropathy.
    Results: We identified 13 patients, Eight women and five men with age ranging from 38-67 y. Follow-up duration ranged from 8 to 12 mo. All patients developed new-onset paresthesias within 2 mo following SARS-CoV-2 infection, with an acute onset in seven and co-existing autonomic symptoms in seven. Three patients had pre-existing but controlled neuropathy risk factors. Skin biopsy confirmed SFN in six, all of whom showed both neuropathy symptoms and signs, and two also showed autonomic dysfunction by autonomic function testing (AFT). Of the remaining seven patients who had normal skin biopsies, six showed no clinical neuropathy signs and one exhibited signs and had abnormal AFT. Two patients with markedly reduced intraepidermal nerve fiber densities and one with normal skin biopsy had severe and moderate coronavirus disease 2019 (COVID-19); the remainder experienced mild COVID-19 symptoms. Nine patients received symptomatic neuropathy treatment with paresthesias controlled in seven (77.8%).
    Discussion: Our findings suggest that symptoms of SFN may develop during or shortly after COVID-19. SFN may underlie the paresthesias associated with long-haul post-COVID-19 symptoms.
    MeSH term(s) COVID-19/complications ; Female ; Humans ; Male ; Peripheral Nervous System Diseases/etiology ; Retrospective Studies ; SARS-CoV-2 ; Small Fiber Neuropathy/complications
    Language English
    Publishing date 2021-11-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 438353-9
    ISSN 1097-4598 ; 0148-639X
    ISSN (online) 1097-4598
    ISSN 0148-639X
    DOI 10.1002/mus.27458
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Safety of Therapeutic Plasma Exchange for the Treatment of Guillain-Barré Syndrome in Polycythemia Vera.

    Abrams, Rory M C / Elder, Gregory A

    The neurologist

    2018  Volume 23, Issue 6, Page(s) 185–187

    Abstract: Polycythemia vera (PV) is a risk factor for systemic thromboses and ischemic stroke. This has been attributed to blood hyperviscosity, the result of increased blood cell production. Intravenous immunoglobulin, which is indicated for the treatment of ... ...

    Abstract Polycythemia vera (PV) is a risk factor for systemic thromboses and ischemic stroke. This has been attributed to blood hyperviscosity, the result of increased blood cell production. Intravenous immunoglobulin, which is indicated for the treatment of numerous hematologic and neurological conditions also causes increased serum viscosity and has been associated with ischemic strokes in the setting of PV. Here we report a case of a 70-year-old man with prior stroke and PV who developed Guillain-Barré syndrome, an acute inflammatory demyelinating disorder of peripheral nerves causing ascending paresis, numbness, and paresthesia, who was treated safely with therapeutic plasma exchange. Plasma exchange may be preferable to administration of intravenous immunoglobulin for treatment of various medical conditions in patients with comorbid PV.
    MeSH term(s) Aged ; Guillain-Barre Syndrome/etiology ; Guillain-Barre Syndrome/therapy ; Humans ; Plasma Exchange/methods ; Polycythemia Vera/complications
    Language English
    Publishing date 2018-10-31
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1361380-7
    ISSN 2331-2637 ; 1074-7931
    ISSN (online) 2331-2637
    ISSN 1074-7931
    DOI 10.1097/NRL.0000000000000197
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: A Case of Elsberg Syndrome in the Setting of Asymptomatic SARS-CoV-2 Infection.

    Abrams, Rory M C / Desland, Fiona / Lehrer, Helaina / Yeung, Anne / Tse, Winona / Young, James J / Mendu, Damodara R / Vickrey, Barbara G / Shin, Susan C

    Journal of clinical neuromuscular disease

    2021  Volume 22, Issue 4, Page(s) 228–231

    Abstract: Abstract: Elsberg syndrome is a rare cause of lumbosacral radiculitis with concomitant thoracic and lumbosacral myelitis that can be seen after an acute or reactivated viral infection. After the initial coronavirus surge in New York City, a 68-year-old ... ...

    Abstract Abstract: Elsberg syndrome is a rare cause of lumbosacral radiculitis with concomitant thoracic and lumbosacral myelitis that can be seen after an acute or reactivated viral infection. After the initial coronavirus surge in New York City, a 68-year-old man developed progressive lower extremity weakness and a defined sensory level at the lower abdomen. He had highly elevated SARS-CoV-2 IgG antibodies despite an absence of preceding COVID-19 symptoms. Serial electrodiagnostic testing revealed absent lower extremity late responses, with otherwise normal distal sensorimotor conductions. Electromyography revealed active neurogenic changes and reduced motor unit recruitment in the L3-L4 myotomes. Treatment with methylprednisolone and intravenous immunoglobulin was followed by minimal clinical improvement but re-emergence of the lower extremity late responses on electrodiagnostic testing. We report here, to the best of our knowledge, the first case of suspected COVID-19-associated Elsberg syndrome, which expands the spectrum of neuromuscular manifestations associated with SARS-CoV-2 infection and sheds light on ways to approach diagnostic and treatment options for these patients.
    MeSH term(s) Aged ; Anti-Inflammatory Agents/therapeutic use ; COVID-19/complications ; Electrodiagnosis ; Electromyography ; Humans ; Immunoglobulin G/analysis ; Magnetic Resonance Imaging ; Male ; Methylprednisolone/therapeutic use ; Muscle Weakness/etiology ; Myelitis/diagnosis ; Myelitis/etiology ; Neural Conduction ; Radiculopathy/diagnosis ; Radiculopathy/etiology ; Spine/diagnostic imaging ; Syndrome ; Treatment Outcome
    Chemical Substances Anti-Inflammatory Agents ; Immunoglobulin G ; Methylprednisolone (X4W7ZR7023)
    Language English
    Publishing date 2021-02-25
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1454947-5
    ISSN 1537-1611 ; 1522-0443
    ISSN (online) 1537-1611
    ISSN 1522-0443
    DOI 10.1097/CND.0000000000000369
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.

    Abrams, Rory M C / Kim, Brian D / Markantone, Desiree M / Reilly, Kaitlin / Paniz-Mondolfi, Alberto E / Gitman, Melissa R / Choo, S Yoon / Tse, Winona / Robinson-Papp, Jessica

    Journal of neurovirology

    2020  Volume 26, Issue 5, Page(s) 797–799

    Abstract: There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an increased occurrence of Guillain-Barré syndrome (GBS). It is currently unknown ... ...

    Abstract There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an increased occurrence of Guillain-Barré syndrome (GBS). It is currently unknown whether concomitant SARS-CoV-2 infection and GBS are pathophysiologically related, what biomarkers are useful for diagnosis, and what is the optimal treatment given the medical comorbidities, complications, and simultaneous infection. We report a patient who developed severe GBS following SARS-CoV-2 infection at the peak of the initial COVID-19 surge (April 2020) in New York City and discuss diagnostic and management issues and complications that may warrant special consideration in similar patients.
    MeSH term(s) Acute Disease ; Aged ; Anticoagulants/therapeutic use ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/pathology ; Coronavirus Infections/therapy ; Coronavirus Infections/virology ; Disease Progression ; Enoxaparin/therapeutic use ; Female ; Guillain-Barre Syndrome/complications ; Guillain-Barre Syndrome/pathology ; Guillain-Barre Syndrome/therapy ; Guillain-Barre Syndrome/virology ; Humans ; Hyponatremia/complications ; Hyponatremia/pathology ; Hyponatremia/therapy ; Hyponatremia/virology ; New York City ; Pandemics ; Plasmapheresis ; Pneumonia, Viral/complications ; Pneumonia, Viral/pathology ; Pneumonia, Viral/therapy ; Pneumonia, Viral/virology ; SARS-CoV-2
    Chemical Substances Anticoagulants ; Enoxaparin
    Keywords covid19
    Language English
    Publishing date 2020-07-27
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1283265-0
    ISSN 1538-2443 ; 1355-0284
    ISSN (online) 1538-2443
    ISSN 1355-0284
    DOI 10.1007/s13365-020-00884-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top